Agnese Savini

963 total citations
35 papers, 689 citations indexed

About

Agnese Savini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Agnese Savini has authored 35 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Agnese Savini's work include Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Electrolyte and hormonal disorders (4 papers). Agnese Savini is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers) and Electrolyte and hormonal disorders (4 papers). Agnese Savini collaborates with scholars based in Italy, United Kingdom and Germany. Agnese Savini's co-authors include Rossana Berardi, Stefano Cascinu, Miriam Caramanti, Matteo Santoni, Francesca Morgese, Silvia Rinaldi, Azzurra Onofri, Mariangela Torniai, Ilaria Fiordoliva and Z. Ballatore and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Agnese Savini

31 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnese Savini Italy 15 323 299 166 113 99 35 689
Azzurra Onofri Italy 15 376 1.2× 382 1.3× 193 1.2× 102 0.9× 113 1.1× 39 838
Miriam Caramanti Italy 16 366 1.1× 316 1.1× 151 0.9× 157 1.4× 85 0.9× 28 841
Francesca Morgese Italy 19 335 1.0× 370 1.2× 186 1.1× 94 0.8× 104 1.1× 42 830
Emiliano Tamburini Italy 17 413 1.3× 228 0.8× 103 0.6× 134 1.2× 180 1.8× 81 833
Carlos Artigas Belgium 14 228 0.7× 462 1.5× 263 1.6× 98 0.9× 226 2.3× 51 1.2k
Masaharu Nishikido Japan 18 266 0.8× 403 1.3× 337 2.0× 137 1.2× 326 3.3× 58 1.0k
R. de las Peñas Spain 15 438 1.4× 460 1.5× 330 2.0× 174 1.5× 163 1.6× 63 1.1k
Jean Philippe Spano France 11 418 1.3× 363 1.2× 156 0.9× 220 1.9× 58 0.6× 16 815
Anne-Sophie Veillard Australia 15 261 0.8× 235 0.8× 118 0.7× 82 0.7× 118 1.2× 29 754

Countries citing papers authored by Agnese Savini

Since Specialization
Citations

This map shows the geographic impact of Agnese Savini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnese Savini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnese Savini more than expected).

Fields of papers citing papers by Agnese Savini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnese Savini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnese Savini. The network helps show where Agnese Savini may publish in the future.

Co-authorship network of co-authors of Agnese Savini

This figure shows the co-authorship network connecting the top 25 collaborators of Agnese Savini. A scholar is included among the top collaborators of Agnese Savini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnese Savini. Agnese Savini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berardi, Rossana, Giulia Mentrasti, Nicla La Verde, et al.. (2021). 1609P COVID-19 outbreak repercussions on breast cancer diagnoses and access to treatment: Preliminary data from the COVID-DELAY study. Annals of Oncology. 32. S1149–S1149. 1 indexed citations
2.
Pistelli, Mirco, Valentina Natalucci, Veronica Agostinelli, et al.. (2021). Abstract PD11-03: Assessing the impact of 12 months lifestyle interventions on breast cancer secondary prevention: A modeling approach. Cancer Research. 81(4_Supplement). PD11–3. 1 indexed citations
3.
Berardi, Rossana, Gaia Goteri, Vittorio Paolucci, et al.. (2020). The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions. Journal of Thoracic Disease. 12(12). 7245–7256. 2 indexed citations
4.
Cantini, Luca, Mirco Pistelli, Filippo Merloni, et al.. (2019). Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients. Clinical Breast Cancer. 20(1). e89–e98. 10 indexed citations
5.
6.
Santinelli, Alfredo, Luca Cantini, Filippo Merloni, et al.. (2017). Stromal peritumoral and intratumoral infiltrating lymphocytes: how immunity influences prognosis in triple negative breast cancer. Annals of Oncology. 28. vi31–vi32. 3 indexed citations
7.
Maccaroni, Elena, Riccardo Giampieri, Michela Del Prete, et al.. (2017). Prognostic impact of CA15-3 pre-treatment levels in ovarian cancer patients. Annals of Oncology. 28. vi71–vi72. 1 indexed citations
8.
Merloni, Filippo, Mirco Pistelli, Luca Cantini, et al.. (2017). Role of inflammation parameters in locally advanced breast cancer: the debate is still open. Annals of Oncology. 28. vi37–vi37. 2 indexed citations
9.
Fiordoliva, Ilaria, et al.. (2017). Managing hyponatremia in lung cancer: latest evidence and clinical implications. Therapeutic Advances in Medical Oncology. 9(11). 711–719. 30 indexed citations
10.
Rinaldi, Silvia, Francesca Morgese, Mariangela Torniai, et al.. (2016). Gemcitabine as single agent second line treatment in patients with advanced wild-type EGFR, negative ALK non-small cell lung cancer: a retrospective study. Annals of Oncology. 27. iv15–iv15.
11.
Berardi, Rossana, Ilaria Fiordoliva, M. De Lisa, et al.. (2016). Clinical and Pathologic Predictors of Clinical Outcome of Malignant Pleural Mesothelioma. Tumori Journal. 102(2). 190–195. 8 indexed citations
12.
Berardi, Rossana, Silvia Rinaldi, Miriam Caramanti, et al.. (2016). Hyponatremia in cancer patients: Time for a new approach. Critical Reviews in Oncology/Hematology. 102. 15–25. 49 indexed citations
13.
Berardi, Rossana, Matteo Santoni, Silvia Rinaldi, et al.. (2016). Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials. PLoS ONE. 11(5). e0152079–e0152079. 39 indexed citations
14.
Berardi, Rossana, Miriam Caramanti, Simona Guglielmi, et al.. (2015). Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Supportive Care in Cancer. 23(10). 3095–3101. 49 indexed citations
15.
Santoni, Matteo, Alessandro Conti, Luciano Burattini, et al.. (2014). Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma. Critical Reviews in Oncology/Hematology. 92(3). 208–217. 25 indexed citations
16.
Rossi, Lorena, Matteo Santoni, Simon J. Crabb, et al.. (2014). High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer. Annals of Surgical Oncology. 22(4). 1377–1384. 73 indexed citations
17.
Berardi, Rossana, Gianluca Valeri, Mirco Pistelli, et al.. (2014). Chromium Exposure and Germinal Embryonal Carcinoma: First Two Cases and Review of the Literature. Journal of Toxicology and Environmental Health. 78(1). 1–6. 18 indexed citations
18.
Berardi, Rossana, Miriam Caramanti, Ilaria Fiordoliva, et al.. (2014). Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma. Supportive Care in Cancer. 23(3). 621–626. 29 indexed citations
19.
Berardi, Rossana, M. De Lisa, Azzurra Onofri, et al.. (2013). Thymic neoplasms: An update on the use of chemotherapy and new targeted therapies. A literature review. Cancer Treatment Reviews. 40(4). 495–506. 11 indexed citations
20.
Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. European Journal Of Haematology. 84(6). 474–483. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026